Get started
Moderna, Inc.Moderna, Inc.Moderna, Inc.

Moderna, Inc.

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsETFs

Chart


Full chart

Key facts today


Moderna is scheduled to report its earnings on February 13, 2026, as part of a series of corporate earnings announcements.
Analyze the impactAnalyze the impact

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.56 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6.870 EUR
Net income (FY)
‪−3.44 B‬ EUR
Revenue (FY)
‪3.13 B‬ EUR
Shares float
‪357.38 M‬
Beta (1Y)
1.40

Employees


Employees (FY)
‪5.8 K‬
Change (1Y)
+200 +3.57%
Revenue / Employee (1Y)
‪538.95 K‬ EUR
Net income / Employee (1Y)
‪−593.08 K‬ EUR

About Moderna, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Stéphane Bancel
Website
modernatx.com
Headquarters
Cambridge
Founded
2010
IPO date
Dec 7, 2018
Identifiers
3
ISIN US60770K1079
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Check out other big names from the same industry as 0QF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


VTI
Vanguard Total Stock Market ETF
Weight
0.02%
Market value
‪324.93 M‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.02%
Market value
‪259.62 M‬
USD
VB
Vanguard Small-Cap ETF
Weight
0.14%
Market value
‪234.90 M‬
USD
RSP
Invesco S&P 500 Equal Weight ETF
Weight
0.27%
Market value
‪227.99 M‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.02%
Market value
‪183.34 M‬
USD
SPY
State Street SPDR S&P 500 ETF
Weight
0.02%
Market value
‪166.86 M‬
USD
VBR
Vanguard Small Cap Value ETF
Weight
0.25%
Market value
‪151.95 M‬
USD
XBI
State Street SPDR S&P Biotech ETF
Weight
1.77%
Market value
‪134.63 M‬
USD
XLV
State Street Health Care Select Sector SPDR ETF
Weight
0.25%
Market value
‪104.74 M‬
USD
IBB
iShares Biotechnology ETF
Weight
1.21%
Market value
‪103.32 M‬
USD
FBT
First Trust NYSE Arca Biotechnology Index Fund
Weight
4.01%
Market value
‪96.85 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 0QF is 34.840 EUR — it has increased by 0.16% in the past 24 hours. Watch Moderna, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Moderna, Inc. stocks are traded under the ticker 0QF.
0QF stock has fallen by −2.20% compared to the previous week, the month change is a 20.06% rise, over the last year Moderna, Inc. has showed a 8.52% increase.
We've gathered analysts' opinions on Moderna, Inc. future price: according to them, 0QF price has a max estimate of 114.25 EUR and a min estimate of 14.39 EUR. Watch 0QF chart and read a more detailed Moderna, Inc. stock forecast: see what analysts think of Moderna, Inc. and suggest that you do with its stocks.
0QF reached its all-time high on Aug 10, 2021 with the price of 431.450 EUR, and its all-time low was 10.550 EUR and was reached on Aug 7, 2019. View more price dynamics on 0QF chart.
See other stocks reaching their highest and lowest prices.
0QF stock is 2.59% volatile and has beta coefficient of 1.40. Track Moderna, Inc. stock price on the chart and check out the list of the most volatile stocks — is Moderna, Inc. there?
Today Moderna, Inc. has the market capitalization of ‪13.56 B‬, it has decreased by −3.53% over the last week.
Yes, you can track Moderna, Inc. financials in yearly and quarterly reports right on TradingView.
Moderna, Inc. is going to release the next earnings report on Feb 13, 2026. Keep track of upcoming events with our Earnings Calendar.
0QF earnings for the last quarter are −0.43 EUR per share, whereas the estimation was −1.60 EUR resulting in a 72.79% surprise. The estimated earnings for the next quarter are −2.17 EUR per share. See more details about Moderna, Inc. earnings.
Moderna, Inc. revenue for the last quarter amounts to ‪865.83 M‬ EUR, despite the estimated figure of ‪784.75 M‬ EUR. In the next quarter, revenue is expected to reach ‪540.78 M‬ EUR.
0QF net income for the last quarter is ‪−170.44 M‬ EUR, while the quarter before that showed ‪−700.35 M‬ EUR of net income which accounts for 75.66% change. Track more Moderna, Inc. financial stats to get the full picture.
No, 0QF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 9, 2026, the company has ‪5.8 K‬ employees. See our rating of the largest employees — is Moderna, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Moderna, Inc. EBITDA is ‪−2.77 B‬ EUR, and current EBITDA margin is −116.07%. See more stats in Moderna, Inc. financial statements.
Like other stocks, 0QF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Moderna, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Moderna, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Moderna, Inc. stock shows the sell signal. See more of Moderna, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.